(Q37599664)

21 August 2017

1 reference

title

Receptor-targeted anticancer therapy (English)

1 reference

21 August 2017

Ben K Seon

1

1 reference

21 August 2017

Yuro Haruta

2

1 reference

21 August 2017

Fumihiko Matsuno

3

1 reference

21 August 2017

Akinao Haba

4

1 reference

21 August 2017

Norihiko Takahashi

5

1 reference

21 August 2017

Xinwei She

6

1 reference

21 August 2017

Naoko Harada

7

1 reference

21 August 2017

Shima Uneda

8

1 reference

21 August 2017

Masanori Tsujie

9

1 reference

21 August 2017

Tomoko Tsujie

10

1 reference

21 August 2017

Hirofumi Toi

11

1 reference

21 August 2017

Hilda Tsai

12

1 reference

21 August 2017

1 March 2010

1 reference

21 August 2017

1 reference

21 August 2017

46

1 reference

21 August 2017

1-3

1 reference

21 August 2017

189-191

1 reference

Anti-tumor activity of an anti-endoglin monoclonal antibody is enhanced in immunocompetent mice

21 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4353395

Isolation and chemical characterization of the human B29 and mb-1 proteins of the B cell antigen receptor complex

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4353395

Distinct human leukemia-associated cell surface glycoprotein GP160 defined by monoclonal antibody SN6.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4353395

Antibody-drug conjugates targeted to CD79 for the treatment of non-Hodgkin lymphoma

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4353395

Antiangiogenic chimeric anti-endoglin (CD105) antibody: pharmacokinetics and immunogenicity in nonhuman primates and effects of doxorubicin.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4353395

Long-lasting complete inhibition of human solid tumors in SCID mice by targeting endothelial cells of tumor vasculature with antihuman endoglin immunotoxin.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4353395

Three new monoclonal antibodies that define a unique antigen associated with prolymphocytic leukemia/non-Hodgkin's lymphoma and are effectively internalized after binding to the cell surface antigen

1 September 2018

1 reference

12 December 2020

Identification of a human endothelial cell antigen with monoclonal antibody 44G4 produced against a pre-B leukemic cell line

1 reference

12 December 2020

Induction of lasting complete regression of preformed distinct solid tumors by targeting the tumor vasculature using two new anti-endoglin monoclonal antibodies

1 reference

12 December 2020

Association of serum endoglin with metastasis in patients with colorectal, breast, and other solid tumors, and suppressive effect of chemotherapy on the serum endoglin

1 reference

12 December 2020

10.1007/S12026-009-8131-8

Identifiers

DOI

1 reference

21 August 2017

1 reference

21 August 2017

PubMed publication ID

19763887

1 reference